Trial intelligence / Profile preview

Mannitol for Cerebral Oxygen Saturation in Laparoscopic Cholecystectomy

NCT02091180Phase 4Completed

Sponsor
Imam Abdulrahman Bin Faisal University
Start
Jan 2013
Primary completion
Nov 2013
Modality
Inhalation Devices, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Bronchitol in intracranial hypertension (IH) and Cerebral Hypoxia (2 arms), sponsored by Imam Abdulrahman Bin Faisal University. Primary endpoint: Cerebral Oxygen Saturation. Started Jan 2013; status: completed.

02

Drugs

Bronchitol
03

Conditions

intracranial hypertension (IH)Cerebral Hypoxia

Beyond the preview

Go deeper on NCT02091180.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02091180.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call